Active surveillance in low-risk prostate cancer. Patient acceptance and results;Vigilancia activa en cáncer de próstata de bajo riesgo. Aceptación por el paciente y resultados

Actas Urologicas Espanolas

Volumn 37, Issue 9, 2013, Pages 533-537

  Hernandez V ^a   Blazquez C ^a   De La Pena E ^a   Perez Fernandez E ^a   Diaz F J ^a   Llorente, C ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Active surveillance; Prostate cancer; Treatment results

Indexed keywords

ACTIVE SURVEILLANCE; ADENOCARCINOMA; AGED; ARTICLE; CÁNCER DE PRÓSTATA; HUMAN; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE TUMOR; RESULTADOS DEL TRATAMIENTO; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT RESULTS; VIGILANCIA ACTIVA; WATCHFUL WAITING;

ACTIVE SURVEILLANCE; CÁNCER DE PRÓSTATA; PROSTATE CANCER; RESULTADOS DEL TRATAMIENTO; TREATMENT RESULTS; VIGILANCIA ACTIVA;

ADENOCARCINOMA; AGED; HUMANS; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 84884595755     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2013.02.010     Document Type: Article

References (13)

1. I. Thompson, J.B. Thrasher, G. Aus, A.L. Burnett, E.D. Canby-Hagino, and M.S. Cookson Guideline for the management of clinically localized prostate cancer J Urol 177 2007 2106 2131
2. A. Heidenreich, J. Bellmunt, M. Bolla, S. Joniau, M. Mason, and V. Matveev EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease Actas Urol Esp 35 2011 501 514
3. J. Mohler, R.R. Bahnson, B. Boston, J.E. Busby, A. D'Amico, and J.A. Eastham NCCN clinical practice guidelines in oncology: Prostate cancer J Natl Compr Canc Netw 8 2010 162 200
4. R. Cheung In regards to Roach et al. defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 66 2006 1274
5. C. Nuñez, J. Angulo, M. Sanchez-Chapado, S. Alonso, J.A. Portillo, and H. Villavicencio Variability of the urological clinical practice in prostate cancer in Spain Actas Urol Esp 36 2012 333 339
6. C.D. Vera Donoso Are we overtreating low risk prostate cancer? Actas Urol Esp 36 2012 66
7. J.J. Tosoian, B.J. Trock, P. Landis, Z. Feng, J.I. Epstein, and A.W. Partin Active surveillance program for prostate cancer: An update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
8. L. Klotz, L. Zhang, A. Lam, R. Nam, A. Mamedov, and A. Loblaw Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
9. M.A. Dall'Era, B.R. Konety, J.E. Cowan, K. Shinohara, F. Stauf, and M.R. Cooperberg Active surveillance for the management of prostate cancer in a contemporary cohort Cancer 112 2008 2664 2670
10. R.C. Van den Bergh, H. Vasarainen, H.G. van der Poel, J.J. Vis-Maters, J.B. Rietbergen, and T. Pickles Short-term outcomes of the prospective multicentre «Prostate Cancer Research International: Active Surveillance» study BJU Int 105 2010 956 962
11. M.A. Dall'era, P.C. Albertsen, C. Bangma, P.R. Carroll, H.B. Carter, and M.R. Cooperberg Active surveillance for prostate cancer: A systematic review of the literature Eur Urol 62 2012 976 983
12. A. Adamy, D.S. Yee, K. Matsushita, A. Maschino, A. Cronin, and A. Vickers Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer J Urol 185 2011 477 482
13. C. Warlick, B.J. Trock, P. Landis, J.I. Epstein, and H.B. Carter Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355 357